Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Koroush Gharagozli"'
Autor:
Asra Fazlollahi, Mahdi Zahmatyar, Hossein Alizadeh, Maryam Noori, Nasrin Jafari, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Koroush Gharagozli, Ali-Asghar Kolahi, Saeid Safiri
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background As a natural antioxidant, uric acid plays a protective role against neurodegenerative disorders, including Parkinson’s disease (PD). Therefore, the risk of PD has been found to be lower in people with hyperuricemia. In this arti
Externí odkaz:
https://doaj.org/article/bafc0aaaea184b5e903d1785ad2a9681
Autor:
Hossein Pakdaman, Ali Amini Harandi, Koroush Gharagozli, Farshid Alaeddini, Akram Esfandani, Seyed Hamidreza Mirbehbahani, Taher Doroudi, Pirhossein Kolivand, Parviz Bahrami, Hadi Kazemi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Epilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is dive
Externí odkaz:
https://doaj.org/article/9ddb771057bb4126859a047085d440bf
Autor:
Hossein Pakdaman, Koroush Gharagozli, Mehdi Abbasi, Ali Sobhanian, Ali Bakhshandehpour, Farzad Ashrafi, Mitra Khalilzad, Ali Amini Harandi
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 8, Iss 1, Pp 174-179 (2018)
Background and Aim: Alzheimer disease (AD) is the most common cause of dementia. Currently, there is no disease-modifying therapy for AD. We aimed to evaluate the long-term efficacy and safety of MLC601 in the treatment of AD. Methods: In this open-l
Externí odkaz:
https://doaj.org/article/f67840d9c0d54afa8480171e157ac752
Autor:
Hossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, Hosein Delavar Kasmaei, Farzad Ashrafi, Koroush Gharagozli, Farhad Assarzadegan, Behdad Behnam, Mehran Arabahmadi
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 7, Iss 1, Pp 136-142 (2017)
Background and Aim: Mild cognitive impairment (MCI) is characterized by declined cognitive function greater than that expected for a person’s age. The clinical significance of this condition is its possible progression to dementia. MLC601 is a natu
Externí odkaz:
https://doaj.org/article/0511f6b38e93492ca7d6a4fa17487ee6
Autor:
Hossein Pakdaman, Ali Amini Harandi, Hamidreza Hatamian, Mojgan Tabatabae, Hosein Delavar Kasmaei, Amirhossein Ghassemi, Koroush Gharagozli, Farzad Ashrafi, Pardis Emami Naeini, Mehrnaz Tavakolian, Darush Shahin
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 5, Iss 1, Pp 96-106 (2015)
Background: MLC601 is a possible modulator of amyloid precursor protein processing, and in a clinical trial study MLC601 showed some effectiveness in cognitive function in Alzheimer's disease (AD) patients. We aimed to evaluate the effectiveness and
Externí odkaz:
https://doaj.org/article/c857fc3f0c9a45bfbf24a3ae894ad943
Autor:
Ali Amini Harandi, Hossein Pakdaman, Koroush Gharagozli, Fatemeh Siavoshi, Siavash Shirzadeh Barough, Ehsan Sharifipour, Akram Esfandani, Saba Ilkhani, Fatemeh Sadat Tabatabaei, Seyed Ali Sobhanian
Publikováno v:
Current Aging Science. 16
Background: MLC601 and MLC901 showed neuroprotective and neuroregenerative properties and positive results in the treatment of dementia and cognitive impairment. This study aimed to investigate the long-term benefits of monotherapy with MLC601 and ML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e551ac00183a07b6f9bde2858810de
https://doi.org/10.2174/1874609816666230224111759
https://doi.org/10.2174/1874609816666230224111759
Autor:
Asra Fazlollahi, Mahdi Zahmatyar, Mahta ZareDini, Behnam Golabi, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Koroush Gharagozli, Ali-Asghar Kolahi, Saeid Safiri
Publikováno v:
JAMA Network Open. 6:e239126
ImportanceEpilepsy is one of the most common neurologic disorders globally. Cannabidiol (CBD) has been approved for the treatment of epilepsy, but its use has been associated with several different adverse events (AEs).ObjectiveTo investigate the fre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d896a4ae0b41226549c4ebf0e64aa66
https://doi.org/10.1001/jamanetworkopen.2023.9126
https://doi.org/10.1001/jamanetworkopen.2023.9126
Autor:
Akram Esfandani, Hadi Kazemi, Hossein Pakdaman, Parviz Bahrami, Pirhossein Kolivand, Farshid Alaeddini, Seyed Hamidreza Mirbehbahani, Ali Amini Harandi, Taher Doroudi, Koroush Gharagozli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Epilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is diverse in di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd39301074705a48dc397139824df49
https://doi.org/10.1038/s41598-021-89048-z
https://doi.org/10.1038/s41598-021-89048-z
Autor:
Koorosh Etemad, Koroush Gharagozli, Masoud Etemadifar, Mehri Salari, Farzad Ashrafi, Helia Ashourizadeh
Publikováno v:
Epilepsy & Behavior
Purpose The coronavirus disease 2019 (COVID-19) pandemic has affected people globally, and people with chronic diseases are suffering more in maintaining their mental and physical health. Method This cross-sectional, case–control study assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a221017f886564a044b486bb024a97a1
Autor:
Koroush Gharagozli, Farzad Ashrafi, Ali Amini Harandi, Hosein Delavar Kasmaei, Hossein Pakdaman, Mehdi Abbasi
Publikováno v:
Neurological Sciences. 39:2107-2113
Interferon beta is currently the first line treatment of relapsing-remitting multiple sclerosis (RRMS). Different formulations of interferon beta are available. Avonex and CinnoVex are two interferon beta-1a being prescribed by neurologists in Iran.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0063b0bcaf8c674a5708b40d0b314b57
https://doi.org/10.1007/s10072-018-3550-8
https://doi.org/10.1007/s10072-018-3550-8